TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an announcement.
Integral Diagnostics Ltd. has announced the application for quotation of 299,862 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of a dividend or distribution plan, potentially impacting the company’s financial structure and market presence by increasing its available capital and shareholder base.
The most recent analyst rating on (AU:IDX) stock is a Hold with a A$3.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. operates in the healthcare industry, specializing in diagnostic imaging services. The company focuses on providing high-quality radiology services across Australia and New Zealand, catering to a wide range of medical needs and enhancing patient care through advanced imaging technologies.
Average Trading Volume: 1,094,031
Technical Sentiment Signal: Buy
Current Market Cap: A$1.02B
For detailed information about IDX stock, go to TipRanks’ Stock Analysis page.